← Leaderboards
Sandy Feng
University Of California, San Francisco
$20,152,343
Attributed
$23,976,660
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,976,660 · 9
By mechanism
U01$20,508,025 · 4
R01$1,267,155 · 1
U34$994,611 · 1
P30$632,581 · 1
R34$574,288 · 2
Top collaborators
- Jeffrey A Bluestone7 shared
- Sang-Mo Kang7 shared
- Qizhi Tang7 shared
- David N. Ikle2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Scott S Zamvil$12,721,345
- Iris Karina Gratz$2,275,863
- Carolyn Marie Hendrickson$1,118,757
- Arthur Weiss$25,258,536
- Bibhav Acharya$3,242,608
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverTransplant RecipientsLiver TransplantationTransplantationAcuteSafetyImmuneDoseClinical TrialsNatural ImmunosuppressionImmune ToleranceMorbidity - Disease RatePeripheral BloodTissuesAllograftingImmunologicsNational Institute Of Allergy And Infectious DiseaseChildhoodWithdrawalPharmaceutical PreparationsOrgan TransplantationCollaborationsMediatingMission
Grant awards (31)
EARLY SIGNALS OF THE TRANSITION FROM IMMUNE QUIESCENCE TO ACTIVATION IN THE LIVER ALLOGRAFT MICROENVIRONMENT AND IN THE CIRCULATION$1,468,517
U01 · FY2025 · AI · contact PI
iSYNAPSE: Early signals of the transition from immune quiescence to activation in the liver allograft microenvironment and in the circulation$270,673
R34 · FY2023 · AI · contact PI
Clinical Component$128,632
P30 · FY2022 · DK · contact PI
Clinical Component$128,632
P30 · FY2021 · DK · contact PI
Clinical Component$123,480
P30 · FY2020 · DK · contact PI
PROSPECTIVE LONGITUDINAL STUDY OF IWITH SCREEN FAILURES SECONDARY TO HISTOPATHOLOGY$347,732
R01 · FY2019 · DK · contact PI
Clinical Component$124,433
P30 · FY2019 · DK · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$845,402
U01 · FY2018 · AI · contact PI
PROSPECTIVE LONGITUDINAL STUDY OF IWITH SCREEN FAILURES SECONDARY TO HISTOPATHOLOGY$438,908
R01 · FY2018 · DK · contact PI
Clinical Component$127,404
P30 · FY2018 · DK · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$987,163
U01 · FY2017 · AI · contact PI
Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients$941,479
U01 · FY2017 · AI · contact PI
PROSPECTIVE LONGITUDINAL STUDY OF IWITH SCREEN FAILURES SECONDARY TO HISTOPATHOLOGY$480,515
R01 · FY2017 · DK · contact PI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients$1,806,911
U01 · FY2016 · AI · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$976,841
U01 · FY2016 · AI · contact PI
Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients$941,479
U01 · FY2016 · AI · contact PI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients$1,815,669
U01 · FY2015 · AI · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$982,619
U01 · FY2015 · AI · contact PI
Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients$941,479
U01 · FY2015 · AI · contact PI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients$1,850,913
U01 · FY2014 · AI · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$983,209
U01 · FY2014 · AI · contact PI
Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients$941,479
U01 · FY2014 · AI · contact PI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients$1,997,549
U01 · FY2013 · AI · contact PI
Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients$1,041,984
U01 · FY2013 · AI · contact PI
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"$57,242
R34 · FY2013 · AI · contact PI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients$1,985,332
U01 · FY2012 · AI · contact PI
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"$246,373
R34 · FY2012 · AI · contact PI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients$51,932
U34 · FY2011 · DK · contact PI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients$454,717
U34 · FY2010 · DK · contact PI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients$54,036
U34 · FY2010 · DK · contact PI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients$433,926
U34 · FY2009 · DK · contact PI